Drug Topics Hospital Pharmacists' Report

June 7, 2012

Web Version  |  Manage Your Profile  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

TOP STORY

Mixed results for intensive blood-sugar control

Intensive control of blood-sugar levels among patients with type 2 diabetes mellitus may reduce the risk of microalbuminuria and macroalbuminuria, signs of kidney damage, but evidence is lacking regarding the effect over renal end points, according to the results of a study published May 28 in Archives of Internal Medicine. » More

Continuing Education

Helping your patients control persistent asthma

Working in partnership with patients and physicians, pharmacists can help ensure optimal control of this common disease.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

TODAY'S HEADLINES

Plan to close asthma’s racial, ethnic gap lauded

The Obama administration’s plan to close the racial and ethnic gap on childhood asthma has drawn strong support from the Merck Childhood Asthma Network. » More

CMS wants to reduce antipsychotics use for dementia

The Centers for Medicare & Medicaid Services is partnering with providers, caregivers, and patients to ensure appropriate use of antipsychotic medications for nursing home patients, the government announced last week. » More

Registry for naming biosimilars needed, author says

The industry should collaborate to develop a U.S. Biopharmacopeia Registry of Biopharmaceutical Products to help resolve biosimilar and broader biopharmaceutical nomenclature issues, according to a leading author and publisher. » More

 

Subscribe Now!

You must click here to continue receiving the Drug Topics Hospital Pharmacists' Report

Check these out, too

New breast cancer drugs available earlier

Hospitals fight drug scarcity

Connecticut legalizes medical marijuana

Impact of new oral anticoagulants

Voices

Anticoagulation Update

JP at Large: Pharmacy’s own “1984”

View from the Zoo: Fox in the henhouse

Viewpoints: Guest columnists’ commentary

Regulatory and Legal: News, features, analysis

Meetings and Events

 
Powered by Modern Medicine Advanstar Medical Communications Group

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.